Acadia Pharmaceuticals Shares Down 22.6% Since SmarTrend's Sell Call (ACAD)

SmarTrend identified a Downtrend for Acadia Pharmaceuticals (NASDAQ:ACAD) on September 30th, 2016 at $32.01. In approximately 2 weeks, Acadia Pharmaceuticals has returned 22.62% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.